399 related articles for article (PubMed ID: 23223431)
21. Quantitative and qualitative impairments in GATA2 and myeloid neoplasms.
Shimizu R; Yamamoto M
IUBMB Life; 2020 Jan; 72(1):142-150. PubMed ID: 31675473
[TBL] [Abstract][Full Text] [Related]
22. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia.
Kalra R; Dale D; Freedman M; Bonilla MA; Weinblatt M; Ganser A; Bowman P; Abish S; Priest J; Oseas RS; Olson K; Paderanga D; Shannon K
Blood; 1995 Dec; 86(12):4579-86. PubMed ID: 8541548
[TBL] [Abstract][Full Text] [Related]
23. How I treat myelodysplastic syndromes of childhood.
Locatelli F; Strahm B
Blood; 2018 Mar; 131(13):1406-1414. PubMed ID: 29438960
[TBL] [Abstract][Full Text] [Related]
24. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.
Bödör C; Renneville A; Smith M; Charazac A; Iqbal S; Etancelin P; Cavenagh J; Barnett MJ; Kramarzová K; Krishnan B; Matolcsy A; Preudhomme C; Fitzgibbon J; Owen C
Haematologica; 2012 Jun; 97(6):890-4. PubMed ID: 22271902
[TBL] [Abstract][Full Text] [Related]
25. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
[TBL] [Abstract][Full Text] [Related]
26. Preferential occurrence of spliceosome mutations in acute myeloid leukemia with preceding myelodysplastic syndrome and/or myelodysplasia morphology.
Cho YU; Jang S; Seo EJ; Park CJ; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH; Koh KN; Im HJ; Seo JJ; Park SH; Park YM; Lee JK
Leuk Lymphoma; 2015; 56(8):2301-8. PubMed ID: 25487075
[TBL] [Abstract][Full Text] [Related]
27. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.
Wlodarski MW; Hirabayashi S; Pastor V; Starý J; Hasle H; Masetti R; Dworzak M; Schmugge M; van den Heuvel-Eibrink M; Ussowicz M; De Moerloose B; Catala A; Smith OP; Sedlacek P; Lankester AC; Zecca M; Bordon V; Matthes-Martin S; Abrahamsson J; Kühl JS; Sykora KW; Albert MH; Przychodzien B; Maciejewski JP; Schwarz S; Göhring G; Schlegelberger B; Cseh A; Noellke P; Yoshimi A; Locatelli F; Baumann I; Strahm B; Niemeyer CM;
Blood; 2016 Mar; 127(11):1387-97; quiz 1518. PubMed ID: 26702063
[TBL] [Abstract][Full Text] [Related]
28. G-CSF receptor (CSF3R) mutations in X-linked neutropenia evolving to acute myeloid leukemia or myelodysplasia.
Beel K; Vandenberghe P
Haematologica; 2009 Oct; 94(10):1449-52. PubMed ID: 19794089
[TBL] [Abstract][Full Text] [Related]
29. A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome.
Nakazawa H; Yamaguchi T; Sakai H; Maruyama M; Kawakami T; Kawakami F; Nishina S; Ishikawa M; Kosho T; Ishida F
Int J Hematol; 2021 Aug; 114(2):286-291. PubMed ID: 33759087
[TBL] [Abstract][Full Text] [Related]
30. GATA2 gene analysis in several forms of hematological malignancies including familial aggregations.
Hamadou WS; Mani R; Besbes S; Bourdon V; Youssef YB; Eisinger F; Mari V; Gesta P; Dreyfus H; Bonadona V; Dugast C; Zattara H; Faivre L; Noguchi T; Khélif A; Sobol H; Soua Z
Ann Hematol; 2017 Oct; 96(10):1635-1639. PubMed ID: 28752392
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia].
Király PA; Kállay K; Marosvári D; Benyó G; Szőke A; Csomor J; Bödör C
Orv Hetil; 2016 Feb; 157(8):283-9. PubMed ID: 26876264
[TBL] [Abstract][Full Text] [Related]
32. Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations.
Mir MA; Kochuparambil ST; Abraham RS; Rodriguez V; Howard M; Hsu AP; Jackson AE; Holland SM; Patnaik MM
Cancer Med; 2015 Apr; 4(4):490-9. PubMed ID: 25619630
[TBL] [Abstract][Full Text] [Related]
33. Granulomatous lung disease in a patient with a family history of hematological disorders.
Overbeek MJ; van de Loosdrecht AA; Vonk-Noordegraaf A
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):350-3. PubMed ID: 25591147
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.
Liao R; Xu Y; Chen M; Chen X; Zhan X; Sun J
Hematology; 2013 Jul; 18(4):191-7. PubMed ID: 23321417
[TBL] [Abstract][Full Text] [Related]
35. Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary.
Király AP; Kállay K; Gángó A; Kellner Á; Egyed M; Szőke A; Kiss R; Vályi-Nagy I; Csomor J; Matolcsy A; Bödör C
Pathol Oncol Res; 2018 Jan; 24(1):83-88. PubMed ID: 28357685
[TBL] [Abstract][Full Text] [Related]
36. GATA2 mutations lead to MDS and AML.
Hyde RK; Liu PP
Nat Genet; 2011 Sep; 43(10):926-7. PubMed ID: 21956389
[No Abstract] [Full Text] [Related]
37. Acute lymphoblastic leukemia in a patient with MonoMAC syndrome/GATA2 haploinsufficiency.
Koegel AK; Hofmann I; Moffitt K; Degar B; Duncan C; Tubman VN
Pediatr Blood Cancer; 2016 Oct; 63(10):1844-7. PubMed ID: 27232273
[TBL] [Abstract][Full Text] [Related]
38. Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias.
Freedman MH; Alter BP
Semin Hematol; 2002 Apr; 39(2):128-33. PubMed ID: 11957196
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia.
Hahn CN; Brautigan PJ; Chong CE; Janssan A; Venugopal P; Lee Y; Tims AE; Horwitz MS; Klingler-Hoffmann M; Scott HS
Leukemia; 2015 Aug; 29(8):1795-7. PubMed ID: 25676417
[No Abstract] [Full Text] [Related]
40. GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia.
Greif PA; Dufour A; Konstandin NP; Ksienzyk B; Zellmeier E; Tizazu B; Sturm J; Benthaus T; Herold T; Yaghmaie M; Dörge P; Hopfner KP; Hauser A; Graf A; Krebs S; Blum H; Kakadia PM; Schneider S; Hoster E; Schneider F; Stanulla M; Braess J; Sauerland MC; Berdel WE; Büchner T; Woermann BJ; Hiddemann W; Spiekermann K; Bohlander SK
Blood; 2012 Jul; 120(2):395-403. PubMed ID: 22649106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
